European Journal of Neurology · 2016 · 100 citations · 13 references
MedicinePharmacologyPharmacotherapyMovement DisordersNeuropharmacologyPsychopharmacologyDopaminergic PharmacologyMovement Disorder PharmacotherapyNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesParkinson DiseaseParkinsonian DisordersClinical Assessment InterviewsDopamine Receptor AgonistsDopamine-related Movement DisordersDopaminergic Therapy ManagementImpulse ControlParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyParkinson’s Disease Treatment
BACKGROUND AND PURPOSE: Impulse control disorders (ICDs) in Parkinson's disease (PD) are associated primarily with dopamine agonist (DA) use. Comparative surveys of clinical occurrence of impulse control behaviours on longer acting/transdermal DA therapy across age ranges are lacking. The aim of this study was to assess the occurrence of ICDs in PD patients across several European centres treated with short- or long-acting [ropinirole (ROP); pramipexole (PPX)] and transdermal [rotigotine skin patch (RTG)] DAs, based on clinical survey as part of routine clinical care. METHODS: A survey based on medical records and clinical interviews of patients initiating or initiated on DA treatment (both short- and long-acting, and transdermal) across a broad range of disease stages and age groups was performed. RESULTS: Four hundred and twenty-five cases were included [mean age 68.3 years (range 37-90), mean duration of disease 7.5 years (range 0-37)]. ICD frequencies (as assessed by clinical interview) were significantly lower with RTG (4.9%; P < 0.05) compared with any other assessed DAs except for prolonged release PPX (PPX-PR). The rate of ICDs for PPX-PR (6.6%) was significantly lower than for immediate release PPX (PPX-IR) (19.0%; P < 0.05). Discontinuation rates of DA therapy due to ICDs were low. CONCLUSION: Our data suggest a relatively low rate of ICDs with long-acting or transdermal DAs, however these preliminary observational data need to be confirmed with prospective studies controlling for possible confounding factors.
13
Impulse Control Disorders in Parkinson Disease
Daniel Weintraub, Juergen Koester, Marc N. Potenza et al. · Archives of Neurology · 2010 · 1.5K citations
Medicine, Neurology, Psychiatry +15
К. Ray Chaudhuri, Pablo Martínez‐Martín, Anthony H.V. Schapira et al. · Movement Disorders · 2006 · 1.1K citations
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
Daniel Weintraub, Staci Hoops, Judy A. Shea et al. · Movement Disorders · 2009 · 531 citations · Full text
Medicine, Neurology, Psychiatry +16
Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale
Daniel Weintraub, Eugenia Mamikonyan, Kimberly Papay et al. · Movement Disorders · 2011 · 384 citations · Full text
Medicine, Neurology, Psychiatry +16